Home › Kanser sa Prostate › Texas › Fort Worth
Pag-aaral pangklinika para sa Kanser sa Prostate sa Fort Worth, TX
9 pag-aaral para sa Kanser sa Prostate ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Fort Worth (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Nagre-recruitPhase 3
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Nagre-recruitPhase 2
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Nagre-recruitPhase 2
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Nagre-recruitPhase 3
- University of Texas Southwestern Simmons Cancer Center - Fort Worth, Fort Worth
A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
Nagre-recruitPhase 1
- START Dallas-Fort Worth, Fort Worth
A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
Nagre-recruitPhase 3
- Urology Partners of North Texas (UPNT), Fort Worth
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Nagre-recruitPhase 3
- Tarrant County Hospital District/JPS Health Network, Fort Worth
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
Nagre-recruitPhase 1
- START Dallas, Fort Worth
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Nagre-recruitPhase 3
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
Pag-aaral para sa Kanser sa Prostate sa ibang lungsod
- New York City, NY103 pag-aaral
- Houston, TX76 pag-aaral
- Los Angeles, CA61 pag-aaral
- Boston, MA59 pag-aaral
- St. Louis, MO46 pag-aaral
- Chicago, IL45 pag-aaral
- San Francisco, CA45 pag-aaral
- Philadelphia, PA44 pag-aaral
- Baltimore, MD43 pag-aaral
- Nashville, TN42 pag-aaral
- Seattle, WA42 pag-aaral
- Washington, DC38 pag-aaral
Iba pang pag-aaral sa Fort Worth
- Non-Small Cell Lung Cancer18 pag-aaral
- Kanser sa Ovary17 pag-aaral
- Kanser ng Endometrium12 pag-aaral
- Kanser sa Suso11 pag-aaral
- Kanser (lahat ng uri)9 pag-aaral
- Pagkabigo ng Puso7 pag-aaral
- Colorectal Cancer7 pag-aaral
- Triple-Negative Breast Cancer7 pag-aaral
- Metastatic Cancer7 pag-aaral
- Kanser sa Bato (Renal Cell Carcinoma)7 pag-aaral
- Ulcerative Colitis7 pag-aaral
- Degenerasyon ng Macula7 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.